2-[6-fluoro-3-[1-(6-methoxy-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-yl]isoindole-1,3-dione
C28H20FN5O4 — CID 146591778
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-fluoro-3-[1-(6-methoxy-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-yl]isoindole-1,3-dione
2-[6-fluoro-3-[1-(6-methoxy-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-yl]isoindole-1,3-dione (PubChem CID 146591778) has the molecular formula C28H20FN5O4 and a molecular weight of 509.50 g/mol. Its IUPAC name is 2-[6-fluoro-3-[1-(6-methoxy-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-yl]isoindole-1,3-dione.
Molecular Properties
| Compound Name | 2-[6-fluoro-3-[1-(6-methoxy-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-yl]isoindole-1,3-dione |
|---|---|
| PubChem CID | 146591778 |
| Molecular Formula | C28H20FN5O4 |
| Molecular Weight | 509.50 g/mol |
| Exact Mass | 509.15 |
| IUPAC Name | 2-[6-fluoro-3-[1-(6-methoxy-3-pyrazol-1-yl-2-pyridinyl)ethoxy]quinolin-2-yl]isoindole-1,3-dione |
| SMILES | COc1ccc(-n2cccn2)c(C(C)Oc2cc3cc(F)ccc3nc2N2C(=O)c3ccccc3C2=O)n1 |
| InChI | InChI=1S/C28H20FN5O4/c1-16(25-22(33-13-5-12-30-33)10-11-24(32-25)37-2)38-23-15-17-14-18(29)8-9-21(17)31-26(23)34-27(35)19-6-3-4-7-20(19)28(34)36/h3-16H,1-2H3 |
| InChIKey | UBBNTCVSRBSOQN-UHFFFAOYSA-N |
| XLogP | 4.90 |
| TPSA | 99.44 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 509.50 |
| LogP ≤ 5 | 4.90 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146591778 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.